Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03331198
Title Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Juno Therapeutics, a Subsidiary of Celgene
Indications

chronic lymphocytic leukemia

CLL/SLL

Therapies

Lisocabtagene maraleucel

Ibrutinib + Lisocabtagene maraleucel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.